Skip to main content
PLOS One logoLink to PLOS One
. 2019 Aug 29;14(8):e0222154. doi: 10.1371/journal.pone.0222154

Correction: A Novel Synthesized Sulfonamido-Based Gallate—JEZ-C as Potential Therapeutic Agents for Osteoarthritis

Shixiu Wei, Zhenhui Lu, Yunfeng Zou, Xiao Lin, Cuiwu Lin, Buming Liu, Li Zheng, Jinmin Zhao
PMCID: PMC6715217  PMID: 31465511

There are errors in Fig 7. The images appearing in panels (a) C, F and G, as well as (b) G and H are incorrect. The authors have provided a corrected version of Fig 7 here.

Fig 7.

Fig 7

Confocal laser scanning microscopy images showing the viability (a) and distribution of the actin cytoskeleton (b) of chondrocytes cultured in vitro with different concentrations of JEZ-C, GA and SMZ for 6 d: JEZ-C (A. 6.25×10−7 μg/ml; B. 6.25×10−6 μg/ml; C. 6.25×10−5 μg/ml), Control (D. without IL-1β), GA (E. 0.078 μg/ml; F. 0.125 μg/ml; G. 0.156 μg/ml), SMZ (H. 6.25×10−6 μg/ml; I. 6.25×10−5 μg/ml; J. 6.25×10−4 μg/ml); cell seeding density: 2×104/ml (original magnification ×100). Scale bar = 200 μm.

Reference

  • 1.Wei S, Lu Z, Zou Y, Lin X, Lin C, Liu B, et al. (2015) A Novel Synthesized Sulfonamido-Based Gallate—JEZ-C as Potential Therapeutic Agents for Osteoarthritis. PLoS ONE 10(6): e0125930 10.1371/journal.pone.0125930 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES